Discontinuation report CEFTRIAXONE SODIUM FOR INJECTION BP

Last updated on 2021-04-06 History
Report ID 136900
Drug Identification Number 02250306
Brand name CEFTRIAXONE SODIUM FOR INJECTION BP
Common or Proper name Ceftriaxone Sodium For Injection
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) CEFTRIAXONE
Strength(s) 2G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10 x 2g
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-04-05
Remaining supply date 2021-04-05
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2021-04-06 English Compare
v2 2021-04-05 French Compare
v1 2021-04-05 English Compare